The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection
Open accessAbstract
Evidence of significant hearing loss during the early days of use of cisplatin as a chemotherapeutic agent in cancer patients has stimulated research into the causes and treatment of this side effect. It has generally been accepted that hearing loss is produced by excessive generation of reactive oxygen species (ROS) in cell of the cochlea, which led to the development of various antioxidants as otoprotective agents. Later studies show that ROS could stimulate cochlear inflammation, suggesting the use of anti-inflammatory agents for treatment of hearing loss. In this respect, G-protein coupled receptors, such as adenosine A1 receptor (A1AR) and cannabinoid 2 receptors (CB2) have shown efficacy in the treatment of hearing loss in experimental animals by increasing ROS scavenging, suppressing ROS generation or by decreasing inflammation. Inflammation could be triggered by activation of transient receptor potential vanilloid 1 (TRPV1) channels in the cochlea and possibly other TRP channels. Targeting TRPV1 for knockdown has also been shown to be a useful strategy for ensuring otoprotection. Cisplatin entry into cochlear hair cells is mediated by various transporters, inhibitors of which have been shown to be effective for treating hearing loss. Finally, cisplatin-induced DNA damage and activation of the apoptotic process could be targeted for cisplatin-induced hearing loss. This review focuses on recent development in our understanding of the mechanisms underlying cisplatin-induced hearing loss and provide examples of how drug therapies have been formulated based on these mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Caspases: Intracellular Signaling by Proteolysis
Salvesen, G. S., & Dixit, V. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80430-4 · Cited by 2,117
Singh, B. N., Shankar, S., & Srivastava, R. K. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.093 · Cited by 1,602
Death Signal-induced Localization of p53 Protein to Mitochondria
Marchenko, N. D., Zaika, A., & Moll, U. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16202 · Cited by 901
Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877
The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update
Siddiqui, W. A., Ahad, A., & Ahsan, H. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1448-7 · Cited by 696
Vaseva, A. V., & Moll, U. M. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.10.005 · Cited by 618
Knight, K. R. G., Kraemer, D. F., & Neuwelt, E. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5355 · Cited by 542
Lighting up the Senses: FM1-43 Loading of Sensory Cells through Nonselective Ion Channels
Meyers, J. R., MacDonald, R. B., Duggan, A., Lenzi, D., Standaert, D. G., Corwin, J. T., & Corey, D. P. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04054.2003 · Cited by 526
Nox3, a superoxide-generating nadph oxidase of the inner ear
Bánfi, B., Malgrange, B., Knisz, J., Steger, K., Dubois-Dauphin, M., & Krause, K.-H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403046200 · Cited by 467
Ciarimboli, G., Deuster, D., Knief, A., Sperling, M., Holtkamp, M., Edemir, B., Pavenstädt, H., Lanvers-Kaminsky, C., am Zehnhoff-Dinnesen, A., Schinkel, A. H., et al. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090610 · Cited by 444
FM1-43 Dye Behaves as a Permeant Blocker of the Hair-Cell Mechanotransducer Channel
Gale, J. E., Marcotti, W., Kennedy, H. J., Kros, C. J., & Richardson, G. P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07013.2001 · Cited by 442
Marcotti, W., van Netten, S. M., & Kros, C. J. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.085951 · Cited by 331
Mechanism of Cisplatin Ototoxicity: Antioxidant System
Ravi, R., Somani, S. M., & Rybak, L. P. (1995) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1995.tb00167.x · Cited by 319
Self-citationMechanisms of endocochlear potential generation by stria vascularis
Salt, A. N., Mleichar, I., & Thalmann, R. (1987) · The Laryngoscope · doi:10.1288/00005537-198708000-00020 · Cited by 298
Kopke, R. D., Liu, W., Gabaizadeh, R., Jacono, A., Feghali, J. G., Spray, D. C., Garcia, P., Steinman, H., Malgrange, B., Ruben, R. J., et al. (1997) · PubMed · Cited by 266
Self-citationSEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE
Sastry, J., & Kellie, S. J. (2005) · Pediatric Hematology and Oncology · doi:10.1080/08880010590964381 · Cited by 258
Mechanisms of hair cell death and protection
Cheng, A. G., Cunningham, L. L., & Rubel, E. W. (2005) · Current Opinion in Otolaryngology & Head and Neck Surgery · doi:10.1097/01.moo.0000186799.45377.63 · Cited by 243
d-Methionine provides excellent protection from cisplatin ototoxicity in the rat
Campbell, K. C. M., Rybak, L. P., Meech, R. P., & Hughes, L. (1996) · Hearing Research · doi:10.1016/s0378-5955(96)00152-9 · Cited by 240
Self-citationSo, H., Kim, H., Lee, J.-H., Park, C., Kim, Y., Kim, E., Kim, J.-K., Yun, K.-J., Lee, K.-M., Lee, H.-Y., et al. (2007) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-007-0084-9 · Cited by 230
Cisplatin-induced apoptosis in auditory cells: role of death receptor and mitochondrial pathways
Devarajan, P., Savoca, M., Castaneda, M. P., Park, M. S., Esteban-Cruciani, N., Kalinec, G., & Kalinec, F. (2002) · Hearing Research · doi:10.1016/s0378-5955(02)00634-2 · Cited by 204
Wang, J., Ladrech, S., Pujol, R., Brabet, P., Van De Water, T. R., & Puel, J.-L. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1581 · Cited by 203
Gurney, J. G., Tersak, J. M., Ness, K. K., Landier, W., Matthay, K. K., & Schmidt, M. L. (2007) · Pediatrics · doi:10.1542/peds.2007-0178 · Cited by 201
Effect of protective agents against cisplatin ototoxicity.
Rybak, L. P., Husain, K. M., Morris, C., Whitworth, C. A., & Somani, S. M. (2000) · PubMed · Cited by 200
Self-citationA Radical Demise: Toxins and Trauma Share Common Pathways in Hair Cell Death
KOPKE, R., ALLEN, K. A., HENDERSON, D., HOFFER, M., FRENZ, D., & VAN DE WATER, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08641.x · Cited by 200
Oldenburg, J., Kraggerud, S. M., Cvancarova, M., Lothe, R. A., & Fossa, S. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9599 · Cited by 197
Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity
More, S. S., Akil, O., Ianculescu, A. G., Geier, E. G., Lustig, L. R., & Giacomini, K. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-10.2010 · Cited by 176
Ototoxicity From Cisplatin Therapy in Childhood Cancer
Coradini, P. P., Cigana, L., Selistre, S. G. A., Rosito, L. S., & Brunetto, A. L. (2007) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0b013e318059c220 · Cited by 175
Application of Antioxidants and Other Agents to Prevent Cisplatin Ototoxicity
Rybak, L. P., Whitworth, C., & Somani, S. (1999) · The Laryngoscope · doi:10.1097/00005537-199911000-00003 · Cited by 169
Self-citationLynch, E. D., Gu, R., Pierce, C., & Kil, J. (2005) · Hearing Research · doi:10.1016/j.heares.2004.08.002 · Cited by 167
Direct effects of reactive oxygen species on cochlear outer hair cell shape in vitro
Clerici, W. J., DiMartino, D. L., & Prasad, M. R. (1995) · Hearing Research · doi:10.1016/0378-5955(95)00010-2 · Cited by 164
Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea
Alam, S. A., Ikeda, K., Oshima, T., Suzuki, M., Kawase, T., Kikuchi, T., & Takasaka, T. (2000) · Hearing Research · doi:10.1016/s0378-5955(99)00211-7 · Cited by 159
Zhang, M., Liu, W., Ding, D., & Salvi, R. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00286-0 · Cited by 157
Fouladi, M., Chintagumpala, M., Ashley, D. M., Kellie, S. J., Gururangan, S., Hassall, T., Gronewold, L., Stewart, C. F., Wallace, D., Broniscer, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3974 · Cited by 149
Kaur, T., Mukherjea, D., Sheehan, K. E., Jajoo, S., Rybak, L. P., & Ramkumar, V. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.63 · Cited by 148
Self-citationMukherjea, D., Jajoo, S., Whitworth, C. A., Bunch, J. R., Turner, J. G., Rybak, L. P., & Ramkumar, V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1307-08.2008 · Cited by 147
Self-citationCaronia, D., Patiño‐García, A., Milne, R. L., Zalacaín, M., Pita, G., Alonso, M. R., Moreno, L. T., Sierrasesúmaga-Ariznabarreta, L., Benitez, J. J., & González‐Neira, A. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.19 · Cited by 144
Mukherjea, D., Jajoo, S., Kaur, T., Sheehan, K. E., Ramkumar, V., & Rybak, L. P. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3110 · Cited by 144
Self-citationOtotoxicity from high‐dose use of platinum compounds in patients with neuroblastoma
Kushner, B. H., Budnick, A. S., Kramer, K., Modak, S. I., & Cheung, N. V. (2006) · Cancer · doi:10.1002/cncr.22004 · Cited by 141
Megalin mediates renal uptake of heavy metal metallothionein complexes
Klassen, R. B., Crenshaw, K., Kozyraki, R., Verroust, P. J., Tío, L., Atrian, S., Allen, P., & Hammond, T. G. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00233.2003 · Cited by 140
So, H., Kim, H., Kim, Y., Kim, E., Pae, H., Chung, H., Kim, H. J., Kwon, K., Lee, K., Lee, H.-Y., et al. (2008) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-008-0126-y · Cited by 130
Dickey, D. T., Muldoon, L. L., Doolittle, N. D., Peterson, D. R., Kraemer, D. F., & Neuwelt, E. A. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0597-2 · Cited by 120
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
Riedemann, L., Lanvers, C., Deuster, D., Peters, U., Boos, J., Jürgens, H., & Zehnhoff‐Dinnesen, A. A. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500455 · Cited by 119
Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy
Benkafadar, N., Menardo, J., Bourien, J., Nouvian, R., François, F., Decaudin, D., Maiorano, D., Puel, J., & Wang, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606230 · Cited by 112
Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function
Clerici, W. J., & Yang, L. (1996) · Hearing Research · doi:10.1016/s0378-5955(96)00126-8 · Cited by 111
Borse, V., Aameri, R. F. H. A., Sheehan, K. E., Sheth, S., Kaur, T., Mukherjea, D., Tupal, S., Lowy, M. M., Ghosh, S., Dhukhwa, A., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.314 · Cited by 111
Self-citationMorris, E. J., Keramaris, E., Rideout, H. J., Slack, R. S., Dyson, N. J., Stefanis, L., & Park, D. S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05017.2001 · Cited by 110
Kaur, T., Borse, V., Sheth, S., Sheehan, K. E., Ghosh, S., Tupal, S., Jajoo, S., Mukherjea, D., Rybak, L. P., & Ramkumar, V. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3111-15.2016 · Cited by 109
Self-citationCampbell, K. C. M., Meech, R. P., Rybak, L. P., et al. (2003) · Journal of the American Academy of Audiology · doi:10.1055/s-0040-1715719 · Cited by 108
Self-citationMarina, N. M., Chang, K. W., Malogolowkin, M. H., London, W. B., Frazier, A. L., Womer, R. B., Rescorla, F. J., Billmire, D. F., Davis, M. M., Perlman, E. J., et al. (2005) · Cancer · doi:10.1002/cncr.21218 · Cited by 104
Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo
Dai, C., Mangiardi, D. A., Cotanche, D. A., & Steyger, P. S. (2006) · Hearing Research · doi:10.1016/j.heares.2005.11.011 · Cited by 102
Thomas, A. J., Hailey, D. W., Stawicki, T. M., Wu, P., Coffin, A. B., Rubel, E. W., Raible, D. W., Simon, J. A., & Ou, H. C. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3940-12.2013 · Cited by 101
Mukherjea, D., Jajoo, S., Sheehan, K. E., Kaur, T., Sheth, S., Bunch, J. R., Perro, C. A., Rybak, L. P., & Ramkumar, V. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3497 · Cited by 98
Self-citationBarbary, A. E., Altschuler, R. A., & Schacht, J. (1993) · Hearing Research · doi:10.1016/0378-5955(93)90023-t · Cited by 97
Cisplatin-Induced Hair Cell Death Requires STAT1 and Is Attenuated by Epigallocatechin Gallate
Schmitt, N. C., Rubel, E. W., & Nathanson, N. M. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5842-08.2009 · Cited by 96
Zuur, C. L., Simis, Y. J. W., Lansdaal, P. E., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.01.042 · Cited by 93
So, H.-S., Kim, H.-J., Lee, J.-H., Lee, J.-H., Sy, P., Park, C., Kim, Y.-H., Jk, K., Lee, K.-M., Kim, K.-S., et al. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401863 · Cited by 89
Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin
Mukherjea, D., Whitworth, C. A., Nandish, S., Dunaway, G., Rybak, L. P., & Ramkumar, V. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.12.044 · Cited by 83
Self-citationSuperoxide dismutase activity in the cochlea
Pierson, M. G., & Gray, B. H. (1982) · Hearing Research · doi:10.1016/0378-5955(82)90050-8 · Cited by 78
Mechanism of endocochlear potential generation by stria vascularis
Salt, A. N., Melichar, I., & Thalmann, R. (1987) · The Journal of the Acoustical Society of America · doi:10.1121/1.2024413 · Cited by 76
Schwartz, I. R., Seidman, M. D., Quirk, W. S., Nuttall, A. L., & Schweitzer, V. G. (1991) · Otolaryngology · doi:10.1177/019459989110500318 · Cited by 74
Sound preconditioning therapy inhibits ototoxic hearing loss in mice
Roy, S., Ryals, M. M., van den Bruele, A. B., Fitzgerald, T. S., & Cunningham, L. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci71353 · Cited by 71
Adenosine and the Auditory System
Vlajkovic, S. M., Housley, G. D., & Thorne, P. R. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152155 · Cited by 59
Protection against cisplatin ototoxicity by adenosine agonists
Whitworth, C. A., Ramkumar, V., Jones, B., Tsukasaki, N., & Rybak, L. P. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.01.010 · Cited by 59
Self-citationImmunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs
van Ruijven, M. W. M., de Groot, J. C. M. J., Hendriksen, F. G. J., & Smoorenburg, G. F. (2005) · Hearing Research · doi:10.1016/j.heares.2004.12.007 · Cited by 58
Church, M. W., Blakley, B. W., Burgio, D. L., & Gupta, A. K. (2004) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-004-4011-z · Cited by 57
Heat Shock Protein-Mediated Protection Against Cisplatin-Induced Hair Cell Death
Baker, T. G., Roy, S., Brandon, C. S., Kramarenko, I. I., Francis, S. P., Taleb, M., Marshall, K. M., Schwendener, R. A., Lee, F., & Cunningham, L. L. (2014) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-014-0491-7 · Cited by 46
Jeong, H., Kim, S., Moon, P., Kim, N., Kim, J., Park, R., Kim, M., Park, B. R., Jeong, S., Um, J., et al. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21168 · Cited by 42
Proapoptotic effects of NF-κB on cisplatin-induced cell death in auditory cell line
Chung, W., Boo, S. H., Chung, M. K., Lee, H.-S., Cho, Y., & Hong, S. H. (2008) · Acta Oto-Laryngologica · doi:10.1080/00016480701881811 · Cited by 36
Inflammasome activation in mouse inner ear in response to MCMV induced hearing loss
Shi, X., Dong, Y., Li, Y., Zhao, Z., Li, H., Qiu, S., Li, Y., Guo, W., & Qiao, Y. (2015) · Journal of Otology · doi:10.1016/j.joto.2015.12.001 · Cited by 29
Martín‐Saldaña, S., Trinidad, A., Ramil, E., Sánchez, A., Coronado, M. J., Martínez-Martínez, E., García, J. M., García‐Berrocal, J. R., & Ramírez‐Camacho, R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161954 · Cited by 27
Rainey, R. N., Ng, S.-Y., Llamas, J., van der Horst, G. T. J., & Segil, N. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3890-15.2016 · Cited by 22
Adenosine amine congener ameliorates cisplatin-induced hearing loss
Gunewardene, N. (2013) · World Journal of Otorhinolaryngology · doi:10.5319/wjo.v3.i3.100 · Cited by 17
Cited by
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
The double-edged roles of ROS in cancer prevention and therapy
Wang, Y., Qi, H., Liu, Y., Duan, C., Liu, X., Xia, T., Chen, D., Piao, H.-L., & Liu, H.-X. (2021) · Theranostics · doi:10.7150/thno.56747 · Cited by 634
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Metadata
- Authors
- Sheth, S., Mukherjea, D., Rybak, L. P., & Ramkumar, V.
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-10-27
- Volume
- 11
- Pages
- 338-338
- ISSN
- 1662-5102 (ISSN-L)
- OpenAlex
- W2765087544
- Cited by
- 361
- References
- 74
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.